Most patients carrying severe mutations (i.e. Class I–III) on both alleles have a pancreatic insufficient (PI-CF) phenotype, while patients who carry a mild mutation on at least one allele, and thus have residual CFTR function, are usually are pancreatic sufficient (PS-CF)3, 4, 5. This evidence concerns the gene CFTR and cystic fibrosis.